Pfizer drug effective in smoking cessation studies (Reuters


Reuters - An experimental smoking cessation drug
by Pfizer Inc. was more effective than GlaxoSmithKline Plc's
Zyban and far more effective than a placebo in helping smokers
quit the habit in important late-stage studies, researchers
said on Tuesday.